Psychiatry of old age is coming of age.
Psychiatry of old age is coming of age.
复制标题
老年精神病学正在走向成熟。
DOI:
10.1176/ajp.154.10.1356
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Jeste,DV
中科院分区:
文献类型:
--
作者:
Jeste,DV
Many a Nobel prize has been awarded to scientists in their 60s or 70s for the work that they had done in their early adulthood. It is rare, however, for the Nobel laureate to have suffered from the ravages of schizophrenia in the intervening time period. Such is the story of John F. Nash, Ph. D., which was published in the New York Times in 1994 (2). Dr. Nash, a mathematician, received the Nobel prize in economics at the age of 66 for the work on game theory that he had done in his 20s. In 1958, when he was 30 years old, Dr. Nash was diagnosed with paranoid schizophrenia; he spent the next 25 years of his life being treated, as an inpatient and as an outpatient, with medications and psychotherapy. He is described as having fearful delusions and disordered thinking. He became “a mute figure who scribbled strange equations on blackboards in the mathematics building and searched anxiously for secret messages in numbers”(2). He did not publish a scientific paper after 1958, nor did he hold an academic post after 1959. Fortunately for him, Dr. Nash had considerable psychosocial support from his family and friends. By his mid-50s, he began to come out of his isolation, starting to work on mathematics and communicating with peers again. The most clear sign of his remarkable recovery was his use of the computer in ingenious ways. A number of clinical researchers who have followed patients with schizophrenia into old age have found that 20% to 35% of these patients, even after decades of illness, have remission or at least marked improvement in their later years.Whatever implications the possibility of “remission” of schizophrenia in old age may have for researchers (and it does have several), at least it should suggest that aging is not all gloom and doom. In psychiatry, one small but interesting example of a positive effect of aging is that the risk of neuroleptic-induced acute dystonia is actually much lower in the elderly than it is in younger adults. The point to stress here is not that aging is necessarily wonderful (although it can be) but that it has heterogeneous effects on the functioning of the brain as well as other organ systems. The importance of geriatrics and gerontology is highlighted by the epidemiologic statistics. Two-thirds of all the people in the entire history of the world who have reached the age of 65 are alive today (3). Moreover, half of the women in the United States who are 65 today will survive to the age of 85 (4). From 1980 to 1990, the population older than 85 years in the United States grew by 40%, and the number of centenarians doubled (4). The statistics on the mentally ill are not available, but it is possible that, given the recent (and expected) advances in the psychopharmacological and other treatments of cognitive, mood, and psychotic disorders, the longevity of psychiatric patients could increase by an even greater proportion than that of the general population. The mental health professionals’ task will be to help implement President Kennedy’s suggestion that new life be added to later years (1). The one thing that could torpedo this optimistic scenario is an adverse change in the delivery of health care services to chronically mentally ill patients. There is a great